STOCK TITAN

[SCHEDULE 13G] Super League Enterprise, Inc. Passive Investment Disclosure (>5%)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Super League Enterprise, Inc. received a Schedule 13G filing from Empery Asset Management, LP and Ryan M. Lane reporting beneficial ownership of 1,275,475 shares of its common stock, including 25,486 shares issuable upon exercise of warrants. This stake represents 9.99% of the common stock, based on 12,742,039 shares outstanding, which reflects 11,492,050 shares outstanding as of November 19, 2025 plus 1,249,989 shares issued upon warrant exercises through December 31, 2025.

The filing explains that the warrants are subject to a 9.99% ownership cap, so not all warrants can be exercised at once. Empery Asset Management is investment manager to the funds that hold the securities, and Lane may be deemed a beneficial owner through his control positions, though both disclaim beneficial ownership beyond their indirect roles. The securities are stated to be held in the ordinary course of business and not for the purpose of changing or influencing control of the company.

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Includes 25,486 shares of Common Stock issuable upon exercise of the Warrants (as defined in Item 2(a)).


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 25,486 shares of Common Stock issuable upon exercise of the Warrants.


SCHEDULE 13G



Empery Asset Management, LP
Signature:/s/ Ryan M. Lane
Name/Title:By: Ryan M. Lane, Authorized Signatory
Date:01/22/2026
Ryan M. Lane
Signature:/s/ Ryan M. Lane
Name/Title:Ryan M. Lane, individually
Date:01/22/2026
Exhibit Information

Exhibit 99.1: Joint Filing Agreement